Prof. Dr. Iris Pigeot - Schriftenverzeichnis Publikationen mit peer - BIPS

More documents

Recommendations

Info

25. Pigeot I (2001) The bootstrap percentile in FDA regulations for bioequivalence assessment. Drug Information Journal 35: 1445-1453. 26. Didelez V, Pigeot I, Dean K, Wister A (2002) A comparative analysis of graphical interaction and logistic regression modelling: self-care and coping with a chronic illness in later life. Biometrical Journal 44: 410- 432. 27. Caputo A, Foraita R, Klasen S, Pigeot I (2003) Undernutrition in Benin - An analysis based on graphical models. Social Science and Medicine 56: 1677-1691. 28. Pigeot I, Schäfer J, Röhmel J, Hauschke D (2003) Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo. Statistics in Medicine 22: 883-899. 29. Timm J, Ahrens W, Pigeot I (2003) Methodische Aspekte der Risikoabschätzung. Bundesgesundheitsbl- Gesundheitsforsch-Gesundheitsschutz 46: 555-563 30. Pigeot I, Bammann K, Reineke A, Wawro N, Zierer A (2004) Statistical methods in genetics: From microarrays to genetic epidemiology – an overview. Invited Paper. Jahresbericht der DMV 106: 3-38. 31. Pigeot I, Bosche H, Pohlabeln H (2004) Programme der Primärprävention von Adipositas und Übergewicht im Kindesalter. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 47: 256-265. 32. Pigeot I, Ahrens W, Bödeker W, Weidmann E (2004) Datenbanken als Grundlage für Monitoring- Systeme in der Arzneimittelsicherheit. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 47: 513-517. 33. Röhmel J, Hauschke D, Koch A, Pigeot I (2005) Biometrische Verfahren zum Wirksamkeitsnachweis im Zulassungsverfahren: Nicht-Unterlegenheit in klinischen Studien. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 48: 562-571. 34. Pigeot I, Windeler J (2005) Klinische Prüfung nach der Zulassung. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 48: 580-585. 35. Bammann K, Pohlabeln H, Pigeot I, Jöckel K-H (2005) Use of an artificial neural network in exploring the dose-response relationship between cigarette smoking and lung cancer risk in males. Far East Journal of Theoretical Statistics 16: 285-302. 36. Hauschke D, Pigeot I (2005) Establishing efficacy of a new experimental treatment in the "Gold Standard" design. Biometrical Journal 47: 782-786 (mit discussion und rejoinder, S. 797-798). 37. Wawro N, Bammann K, Pigeot I (2006) Testing for association in the presence of population stratification: A simulation study comparing the S-TDT, STRAT, and the GC. Biometrical Journal 48: 420-434. 38. Pigeot I, Ahrens W, Kübler J (2006) Datenquellen in der Epidemiologie. Bundesgesundheitsbl Gesundheitsforschung Gesundheitsschutz 49: 628-636. 39. Didelez V, Pigeot I, Walter P (2006) Modifications of the Bonferroni-Holm procedure for a multi-way ANOVA. Statistical Papers 47: 181-209. 40. Ahrens W, Bammann K, De Henauw S, Halford J, Palou A, Pigeot I, Siani A, Sjöström M, on behalf of the European Consortium of the IDEFICS Project (2006) Understanding and preventing childhood obesity and related disorders - IDEFICS: A European multilevel epidemiological approach. Nutrition, Metabolism & Cardiovascular Diseases 16: 302-308. 41. Pigeot I, Ahrens W, Foraita R, Jahn I, Pohlabeln H (2006) Ausgewählte methodische Probleme evidenzbasierter Prävention. Prävention und Gesundheitsförderung 1: 240-247. 42. Bammann K, Peplies J, Sjöström M, Lissner L, De Henauw S, Galli C, Iacoviello L, Krogh V, Marild S, Pigeot I, Pitsiladis Y, Pohlabeln H, Reisch L, Siani A, Ahrens W, on behalf of the IDEFICS Consortium (2006) Assessment of diet, physical activity biological, social and environmental factors in a multi-centre European project on diet- and lifestyle-related disorders in children (IDEFICS). Journal of Public Health 14: 279-289. 43. Güttner A, Kübler J, Pigeot I (2007) Multivariate time-to-event analysis of multiple adverse events of drugs in integrated analyses. Statistics in Medicine 26: 1518-1532. 44. Pigeot I, Ahrens W, Foraita R, Jahn I, Pohlabeln H (2007) Sample selection and outcome evaluation in primary prevention. Journal of Public Health 15: 93-99.
45. Ahrens W, Hagemeier C, Mühlbauer B, Pigeot I, Püntmann I, Reineke A, Steinbach M, Timm J (2007) Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study. Pharmacoepidemiology and Drug Safety 16:1298-1307. 46. Bammann K, Peplies J, Pigeot I, Ahrens W (2007) IDEFICS: ein europäisches multizentrisches Projekt zu ernährungs- und lebensstilbedingten Erkrankungen im Kindesalter. Medizinische Klinik 102: 230-235. 47. Giersiepen K, Pohlabeln H, Egidi G, Pigeot I (2007) Die ICD-Kodierqualität für Diagnosen in der ambulanten Versorgung. Bundesgesundheitsbl Gesundheitsforschung Gesundheitsschutz 50: 1028- 1038. 48. Zierer A, Reineke A, Drutschmann D, Blohm D, Pigeot I (2007) Normalisierungs-Methoden für onechannel Microarrays in der Organismen-Identifikation. GMS Med Inform Biom Epidemiol 3:Doc06 (Artikel online frei zugänglich unter http://www.egms.de/en/journals/mibe/2007-3/mibe000054.shtml). 49. Foraita R, Bammann K, Pigeot I (2008) Modeling gene-gene interaction using graphical chain models. Human Heredity 65: 47-56. 50. Schill W, Wild P, Pigeot I (2008) A planning tool for two-phase case-control data. Computer Methods and Programs in Biomedicine 88: 175-181. 51. Pigeot I, Ahrens W (2008) Establishment of a pharmacoepidemiological database in Germany: Methodological potential, scientific value and practical limitations. Pharmacoepidemiology and Drug Safety 17: 215-223. 52. Ahrens W, Bammann K, Pigeot I (2008) Evidenzbasierung von Primärprävention am Beispiel einer Interventionsstudie zum kindlichen Übergewicht. Prävention und Gesundheitsförderung 3: 246-252. 53. Foraita R, Klasen S, Pigeot I (2008) Using graphical chain models to analyze differences in structural correlates of undernutrition in Benin and Bangladesh. Economics & Human Biology 6: 398-419. 54. Koehne-Voss S, Pigeot I (2009) A point estimator for the time course of drug release. Biometrical Journal 51(1): 146-158. 55. Canova C, Hashibe M, Simonato L, Nelis M, Metspalu A, Lagiou P, Trichopoulos D, Ahrens W, Pigeot I, Merletti F, Richiardi L, Talamini R, Barzan L, Macfarlane GJ, Macfarlane TV, Holcátová I, Bencko V, Benhamou S, Bouchardy C, Kjaerheim K, Lowry R, Agudo A, Castellsagué X, Conway DI, McKinney PA, Znaor A, McCartan BE, Healy CM, Marron M, Brennan P (2009) Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries- the ARCAGE project. Cancer Research 69(7): 2956-2965. 56. Pigeot I, De Henauw S, Foraita R, Jahn I, Ahrens W (2010) Primary prevention from the epidemiology perspective: Three examples from the practice. BMC Medical Research Methodology, 10:10 (Open Access Journal, http://www.biomedcentral.com/1471-2288/10/10) 57. Pigeot I, Barba G, Chadjigeorgiou G, De Henauw S, Kourides Y, Lissner L, Marild S, Pohlabeln H, Russo P, Tornaritis M, Veidebaum T, Wawro N, Siani A (2009) Prevalence and determinants of childhood overweight and obesity in European countries: pooled analysis of the existing 5 surveys within the IDEFICS consortium. Int J Obes 33: 1103–1110. (addressed as Research Highlight in Nature Reviews Endocrinology, Vol. 5, December 2009, p. 639) 58. Sachse MM, Ehrich FH, Pape L, Pigeot I, Jahn I, Bahmer FA (2009) SPF 50 for organ transplant patients –over the top? (Letter to the editor). Comment on the article of Ulrich et al. Sunscreens in organ transplant patients. Nephrol Dial Transplant 23(6): 1805-1808. 59. Röhmel J, Pigeot I (2010) A comparison of multiple testing procedures for the gold standard noninferiority trial. J Biopharm Stat 20(5): 911- 926. 60. Koehne-Voss S, Schmidli H, Smith DM, Pigeot I (2010) The impact of period effects on dose level contrasts in alternating cross-over designs for first-time-in human studies. Pharmaceutical Statistics (online published, early view | DOI: 10.1002/pst.409). 61. Pigeot I, Buck C, Herrmann D, Ahrens W (2010) Übergewicht und Adipositas bei Kindern und Jugendlichen. Die weltweite Situation. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 53(7): 653-665 62. De Henauw S, Verbestel V, Marild S; Barba G, Bammann K, Eiben G, Hebestreit A, Iacoviello L, Keimer KM, Konstabel K, Kovács E, Maes L, Molnar D, Moreno LA, Reisch L, Siani A, Tornaritis M, Williams G, Ahrens W, De Bourdeaudhuij I, Pigeot I; on behalf of the IDEFICS consortium (2010) The IDEFICS community oriented intervention program. A new model for childhood obesity prevention in Europe. Int J Obes (in print).
Page 1: Prof. Dr. Iris Pigeot - Schriftenve
Page 5 and 6: 15. Pigeot I, Strugholtz H (1995) U

Prof. Dr. Iris Pigeot - Schriftenverzeichnis Publikationen mit peer - BIPS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?